Similar articles

• [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].

  Sasaki K, Fujimoto T, Goya N. Sasaki K, et al. Rinsho Ketsueki. 1979 Jan;20(1):90-7. Rinsho Ketsueki. 1979. PMID: 311390 Japanese. No abstract available.
• [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].

  Tsurusawa M, Sasaki K, Matsuoka H, Katano N, Fujimoto T. Tsurusawa M, et al. Gan To Kagaku Ryoho. 1985 Sep;12(9):1827-32. Gan To Kagaku Ryoho. 1985. PMID: 3876075 Japanese.
• [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].

  [No authors listed] [No authors listed] Gan To Kagaku Ryoho. 1982 Mar;9(3):421-32. Gan To Kagaku Ryoho. 1982. PMID: 6764106 Clinical Trial. Japanese.
• [The method of leucovorin administration in high dose methotrexate regimen (author's transl)].

  Taguchi H. Taguchi H. Rinsho Ketsueki. 1981 Nov;22(11):1687-99. Rinsho Ketsueki. 1981. PMID: 7040726 Review. Japanese. No abstract available.
• Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.

  Goldman ID, Matherly LH. Goldman ID, et al. NCI Monogr. 1987;(5):17-26. NCI Monogr. 1987. PMID: 2448654 Review.